MoMelan Technologies (acquired by Kinetic Concepts, Inc.) has developed a novel skin grafting technology to treat skin disorders through the expansion of the surface area of skin grafts.

NinePoint Medical, Inc. is a medical device company integrating multiple technologies to streamline patient care. NinePoint is initially developing novel products for use during minimally invasive procedures such as endoscopy and laparoscopy to provide enhanced diagnostic capabilities and improve outcomes.

NKT Therapeutics is a biotechnology company focused on developing therapeutics based on a unique subset of immune cells called natural killer T (”NKT”) cells.

OvaScience (NASDAQ: OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments.

Seven Oaks Biosystems is an early stage venture developing a minimally invasive device for autologous full-thickness skin transplant for wound healing and reconstructive surgery.